Oaktree Acquisition Corp. III Life Sciences
OACCW- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.65M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Oaktree Acquisition Corp. III Life Sciences changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 28 | 30 | +2 |
| Shares | 2.65M | 2.71M | +56.4K (+2.1%) |
| Value | $2.19M | $2.09M | −$98.2K (−4.5%) |
New holders (3)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 105,907 | $74.1K | 0.00% |
| Weiss Asset Management LP | 64,860 | $46.1K | 0.00% |
| DLD Asset Management, LP | 44,519 | $31.6K | 0.00% |
Sold out (1)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Highbridge Capital Management LLC | – | $75 |